Literature DB >> 31057678

Nuclear Theranostics in Taiwan.

Ko-Han Lin1, Yi-Wei Chen2, Rheun-Chuan Lee3, Ling-Wei Wang2, Fong-In Chou4, Chi-Wei Chang1, Sang-Hue Yen2, Wen-Sheng Huang1.   

Abstract

Boron neutron capture therapy and Y-90 radioembolization are emerging therapeutic methods for uncontrolled brain cancers and hepatic cancers, respectively. These advanced radiation therapies are heavily relied on theranostic nuclear medicine imaging before the therapy for the eligibility of patients and the prescribed-dose simulation, as well as the post-therapy scanning for assessing the treatment efficacy. In Taiwan, the Taipei Veterans General Hospital is the only institute performing the BNCT and also the leading institute performing Y-90 radioembolization. In this article, we present our single institute experiences and associated theranostic nuclear medicine approaches for these therapies.

Entities:  

Keywords:  BNCT; FBPA-PET; Radioembolization; Tc-MAA

Year:  2019        PMID: 31057678      PMCID: PMC6473010          DOI: 10.1007/s13139-019-00576-z

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  23 in total

1.  Comparison of yttrium-90 quantitative imaging by TOF and non-TOF PET in a phantom of liver selective internal radiotherapy.

Authors:  Larry van Elmbt; Stefaan Vandenberghe; Stephan Walrand; Stanislas Pauwels; François Jamar
Journal:  Phys Med Biol       Date:  2011-10-05       Impact factor: 3.609

2.  Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma.

Authors:  Mehrdad Sarfaraz; Andrew S Kennedy; Martin A Lodge; X Allen Li; Xingen Wu; Cedric X Yu
Journal:  Med Phys       Date:  2004-09       Impact factor: 4.071

3.  A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr.

Authors:  R G Selwyn; R J Nickles; B R Thomadsen; L A DeWerd; J A Micka
Journal:  Appl Radiat Isot       Date:  2006-10-11       Impact factor: 1.513

4.  Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

Authors:  Bruno Sangro; Livio Carpanese; Roberto Cianni; Rita Golfieri; Daniele Gasparini; Samer Ezziddin; Philipp M Paprottka; Francesco Fiore; Mark Van Buskirk; Jose Ignacio Bilbao; Giuseppe Maria Ettorre; Rita Salvatori; Emanuela Giampalma; Onelio Geatti; Kai Wilhelm; Ralf Thorsten Hoffmann; Francesco Izzo; Mercedes Iñarrairaegui; Carlo Ludovico Maini; Carlo Urigo; Alberta Cappelli; Alessandro Vit; Hojjat Ahmadzadehfar; Tobias Franz Jakobs; Secondo Lastoria
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

Review 5.  Boron neutron capture therapy of cancer: current status and future prospects.

Authors:  Rolf F Barth; Jeffrey A Coderre; M Graça H Vicente; Thomas E Blue
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

Review 6.  Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.

Authors:  C Chiesa; M Maccauro; R Romito; C Spreafico; S Pellizzari; A Negri; C Sposito; C Morosi; E Civelli; R Lanocita; T Camerini; C Bampo; S Bhoori; E Seregni; A Marchianò; V Mazzaferro; E Bombardieri
Journal:  Q J Nucl Med Mol Imaging       Date:  2011-04       Impact factor: 2.346

7.  BNCT for locally recurrent head and neck cancer: preliminary clinical experience from a phase I/II trial at Tsing Hua Open-Pool Reactor.

Authors:  L W Wang; S J Wang; P Y Chu; C Y Ho; S H Jiang; Y W H Liu; Y H Liu; H M Liu; J J Peir; F I Chou; S H Yen; Y L Lee; C W Chang; C S Liu; Y W Chen; K Ono
Journal:  Appl Radiat Isot       Date:  2011-03-30       Impact factor: 1.513

8.  4-Borono-2-[18F]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography.

Authors:  K Ishiwata; T Ido; M Kawamura; K Kubota; M Ichihashi; Y Mishima
Journal:  Int J Rad Appl Instrum B       Date:  1991

9.  Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres.

Authors:  Yung-Hsiang Kao; Jeffrey D Steinberg; Young-Soon Tay; Gabriel Ky Lim; Jianhua Yan; David W Townsend; Charley A Budgeon; Jan A Boucek; Roslyn J Francis; Timothy St Cheo; Mark C Burgmans; Farah G Irani; Richard Hg Lo; Kiang-Hiong Tay; Bien-Soo Tan; Pierce Kh Chow; Somanesan Satchithanantham; Andrew Eh Tan; David Ce Ng; Anthony Sw Goh
Journal:  EJNMMI Res       Date:  2013-07-25       Impact factor: 3.138

10.  Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization.

Authors:  Mattijs Elschot; Bart J Vermolen; Marnix G E H Lam; Bart de Keizer; Maurice A A J van den Bosch; Hugo W A M de Jong
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more
  2 in total

Review 1.  Radioembolization for the Treatment of Primary and Metastatic Liver Cancers.

Authors:  Eun Jeong Lee; Hyun Woo Chung; Joon-Hyung Jo; Young So
Journal:  Nucl Med Mol Imaging       Date:  2019-11-08

2.  Water-soluble BODIPY-nido-carborane nanoparticles applied to biocompatibility tumor cell imaging.

Authors:  Dongfang Dai; Guangchang Lian; Xia He; Jifeng Feng; Guofan Jin
Journal:  Photochem Photobiol Sci       Date:  2022-01-21       Impact factor: 3.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.